Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AL9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,028
Award facts
- Contract value 100% obligated
- $14,028.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,028.28 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price, non-set-aside delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at approximately $1 billion through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company maintains extensive federal contracting relationships with the DLA for a diverse portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities. This delivery order for Zepbound, a diabetes medication, reflects the routine task order activity typical under the company's prime vendor arrangement with the DLA Medical Supply Chain, demonstrating the contractor's ongoing capability to meet federal pharmaceutical supply requirements through competitive contracting mechanisms.
Quick answers
Who was awarded contract SPE2DR26F1AL9?
SPE2DR26F1AL9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1AL9 worth?
The government has obligated $14,028 on SPE2DR26F1AL9.
Is contract SPE2DR26F1AL9 an order under another contract?
Yes. SPE2DR26F1AL9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AL9 competed?
The extent of competition for SPE2DR26F1AL9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award